RE:RE:RE:RE:RE:RE:AGN haltedYou would think that with the study requiring a period of 3 months/patient that those selected could have begun the trial. Those to be selected could have been given a patient trial number to which a patient could be assigned later.
If they could not start the study until ALL patients are enrolled, then how can they complete the study and have results by mid 2021? The investor presentation does not show a change in the results date for top line results. Perhaps the wording on the NR is not accurate.
prophetoffacts wrote: It is not clear that a single patient has even been treated yet. As reported in the November 27, 2020 news release after the COVID delays enrollment of the trial had recommenced and subjects had been randomised to a trial arm. No mention treatments have been administered to anyone yet. - "Resumed enrollment of patients for the clinical trial with beta glucan as a cholesterol reducing natural pharmaceutical product. 191 patients have been screened and 65 randomized during the last three months." news release